[General remarks on the treatment of acute leukemias].
D001215:Asparaginase / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*; D013866:Thioguanine / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D003561:Cytarabine; D014750:Vincristine; D001215:Asparaginase; D013866:Thioguanine; D011241:Prednisone; D003630:Daunorubicin
Osservazioni generali sul trattamento delle leucemie acute